Publications
80
Citations
1,380
Est. group size
~3
Recurring co-author estimate
Active years
34
Publishing since 1993
R. Timothy Bentley works in veterinary neurology and neuro-oncology, focusing on diagnosing and treating brain and spinal cord disorders in dogs and cats, especially brain tumors like meningiomas and gliomas. His work spans clinical case studies, surgical management of brain tumors, and experimental treatments such as oncolytic virus therapy and vaccination approaches for canine brain cancer. This research could interest students wanting to work at the intersection of veterinary clinical practice and translational cancer therapy research.
Publication output has fluctuated over the last decade with no clear steady growth, showing peaks in 2018, 2021, and especially 2023, followed by a decline in more recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Resolution of thoracic limb lameness associated with traumatic suprascapular neuropathy in a dog: case report
Research Square · 2026
- Prognostic Utility of F-Waves in Paraplegic Dogs With Absent Pain Perception Secondary to Intervertebral Disc Extrusion
Journal of Veterinary Internal Medicine · 2025
- Responsiveness of the neurodisability scale for meningoencephalitis of unknown origin in dogs
Journal of Small Animal Practice · 2025
- Surgical Management of Intracranial Meningiomas
2023
- Supplementary Table 3 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Table 2 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Table 1 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Methods from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Table 1 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Methods from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Table 3 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Supplementary Table 2 from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Editorial: Chemotherapy and other pharmacotherapies for canine neurological disorders
Frontiers in Veterinary Science · 2023
- Data from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Data from Vaccination for Invasive Canine Meningioma Induces <i>In Situ</i> Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity
2023
- Veterinary Radiology & Ultrasound×5
- Frontiers in Veterinary Science×4
- Veterinary and Comparative Oncology×3
- Journal of Small Animal Practice×3
- Journal of the American Veterinary Medical Association×3
- William C. Kisseberth
Medicine · The Ohio State University
- Nikolaos Dervisis
Medicine · Purdue University West Lafayette
- Ana Carolina Brandão de Campos Fonseca Pinto
Medicine · Purdue University West Lafayette
- Stephanie A. Thomovsky
Medicine · Purdue University West Lafayette
- Isabelle F. Vanhaezebrouck
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile